Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors

US Patent 11739093 · Granted Aug 29, 2023

Estimated economic value: $24,824,000

Assignee

Inventors

View full patent text on Google Patents →